Therapeutic potential of psychedelic agents

descriptionPublicationkeyboard_double_arrow_right Article 01 May 2015 English Publisher:Royal College of PsychiatristsJournal:British Journal of Psychiatry, volume 206, pages 433-433 (issn: 0007-1250, eissn: 1472-1465,

Copyright policy )

Authors: Rani, Pathania;

doi: 10.1192/bjp.206.5.433

pmid: 25934305

Therapeutic potential of psychedelic agents

- Summary
- Subjects
- Metrics

Abstract

Amphetamine, methylphenidate, morphine, heroin and ketamine are all drugs that can potentially be used clinically but, whenever we hear the word MDMA, the first thoughts that come to mind are of ecstasy, rave parties and people behaving in an odd manner and experiencing hallucinations, paranoia and

Related Organizations

National Health Service
United Kingdom
National Health Service Wales
United Kingdom
Coventry and Warwickshire Partnership NHS Trust
United Kingdom

Keywords

Stress Disorders, Post-Traumatic, Depressive Disorder, Treatment-Resistant, N-Methyl-3,4-methylenedioxyamphetamine, Hallucinogens, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	2
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average